Condition
Breast Implant Revision
Total Trials
6
Recruiting
1
Active
1
Completed
1
Success Rate
25.0%-62% vs avg
Key Insights
Highlights
Success Rate
25% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
50.0%
3 terminated out of 6 trials
Success Rate
25.0%
-61.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
300%
3 of 1 completed with results
Key Signals
3 with results25% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Terminated3
Completed1
Not Yet Recruiting1
Recruiting1
Trial Success Rate
25.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07367698Not ApplicableRecruitingPrimary
Scaffold-guided Breast Implant Revision and Primary Breast Augmentation Surgery
NCT05437757Not ApplicableCompletedPrimary
Scaffold-guided Breast Surgery
NCT07383012Not Yet RecruitingPrimary
LTFU of PCL Breast Scaffolds Used in 2021-BRV-004
NCT01785069Not ApplicableTerminated
Safety and Effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-filled X-Style and L-Style Breast Implants
NCT01870869Not ApplicableTerminated
NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study
NCT01853605Not ApplicableTerminated
NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study
Showing all 6 trials